1. Academic Validation
  2. ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury

ACSL4 deficiency confers protection against ferroptosis-mediated acute kidney injury

  • Redox Biol. 2022 May;51:102262. doi: 10.1016/j.redox.2022.102262.
Yue Wang 1 Menghan Zhang 2 Ran Bi 3 Yali Su 3 Fei Quan 3 Yanting Lin 3 Chongxiu Yue 3 Xinmeng Cui 3 Qixiang Zhao 3 Siliang Liu 3 Yong Yang 3 Dayong Zhang 4 Qiuhua Cao 5 Xinghua Gao 6
Affiliations

Affiliations

  • 1 Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China; Department of Endocrinology, The Second Affiliated Hospital of Anhui Medical University, Hefei, 230601, China.
  • 2 Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China; Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7568, USA.
  • 3 Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China.
  • 4 School of Sciences, China Pharmaceutical University, Nanjing, 211198, China.
  • 5 Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China. Electronic address: 1520210058@cpu.edu.cn.
  • 6 Center for New Drug Safety Evaluation and Research, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, 211198, PR China. Electronic address: gaoxinghua@cpu.edu.cn.
Abstract

The term Ferroptosis coined in 2012 causes acute kidney injury (AKI). However, its pathway mechanism in AKI is poorly understood. In this study, we conducted an RNA-sequence analysis of kidneys in AKI and normal mice to explore the pathway mechanism of Ferroptosis. Consequently, differentially expressed genes highlighted Acyl-CoA synthetase long-chain family (ACSL4), a known promotor for Ferroptosis. Besides, RT-PCR, Western blot, and immunohistochemical analyses confirmed its upregulation. HIF-1α was downregulated in I/R-AKI mice, and in vitro studies confirmed a negative regulation of HIF-1α on ACSL4. To explore the role of ACSL4 in AKI, we constructed ACSL4 knockout in kidney tubules of mice-as Cdh16Cre-ACSL4F/F mice. Results revealed that ACSL4 knockout significantly reduced Ferroptosis and inhibited the functional and pathological injury of AKI mice. Meanwhile, the kidneys of Cdh16Cre-ACSL4F/F mice demonstrated a significantly decreased inflammation and macrophage infiltration. Further, additional explorations were explored to decipher a more thorough understanding of ferroptotic immunogenicity. As a result, neutrophils were not directly recruited by ferroptotic cells, but by ferroptotic cell-induced macrophages. Further, ACSL4 inhibitor rosiglitazone significantly inhibited AKI. Collectively, these data provide novel insights into the AKI pathogenesis, and defined ACSL4 as an effective target in AKI.

Keywords

ACSL4; Acute kidney injury; Ferroptosis; HIF-1α; Macrophages.

Figures
Products